Memorial Şişli Hospital
Memorial Şişli Hospital
Turkey, Istanbul
Serkan Keskin
25 years of experience
accreditations :
Clinic is certified :
Targeted therapy in Turkey generally costs between AUD $1,405 and AUD $6,461 per session. Final expenses depend on the specific molecular markers, drug choice, and necessary diagnostic profiling. Australians typically find the average local price of AUD $15,732 significantly higher, with Turkey offering savings of approximately 75%. Standard inclusions often cover oncologist consultations and airport transfers.
Bookimed Expert Insight: Australian patients gain significant value by accessing multidisciplinary tumor boards at top Istanbul facilities. Anadolu Medical Center, for example, maintains an affiliation with Johns Hopkins Hospital, meaning Western-standard protocols cost much less. Larger institutions like Memorial Göztepe Hospital use AI-supported 3 Tesla MRI and digital PET/CT to refine dosage. This precision often reduces wasted medication costs during treatment.
| Turkey | Thailand | South Korea | |
| Targeted therapy | from AUD $1,405 | from AUD $9,833 | from AUD $7,726 |
| Lutetium-177 therapy | from AUD $14,047 | from AUD $16,856 | from AUD $18,963 |
| Oncothermia | from AUD $632 | from AUD $6,321 | - |
| Actinium-225 Therapy | from AUD $32,244 | from AUD $35,116 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Professor Bulent Karagoz is a leading oncologist at Anadolu Medical Center, having performed over 900 procedures with a strong focus on tumor biology and immunology.
Professor Mustafa Solak gained elite clinical oncology experience at the University of Texas MD Anderson Cancer Center, world-renowned for developing targeted cancer therapies.
Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.
Professor Serkan Keskin is a pioneer in genetic mapping who ranked first in Turkey's national medical oncology proficiency exam. He leads the Oncology Centre at Memorial Şişli Hospital.
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.
Targeted therapy in Turkish clinics uses precision drugs to attack specific cancer molecules while sparing healthy tissue. Centres like Anadolu Medical Center and Memorial Şişli follow ESMO and ASCO guidelines. Treatment begins with genomic profiling to match the tumour’s genetic mutations with the most effective tailored medication.
Bookimed Expert Insight: Turkish oncology hubs often offer radionuclide options like Actinium-225. This therapy costs from $23,000 to $24,700. These therapies are frequently available much sooner than in Australia. They provide a vital alternative for patients with advanced or resistant cancers.
Patient Consensus: Patients in Turkey find the integrated follow-up plans and repeat diagnostic checks very thorough. Many use these clinics for regular second opinions and ongoing reassessment every few months.
Turkey is a leading destination for targeted cancer therapy. This is due to its highly accredited oncology centres and rapid access to precision medicine. Leading hospitals in Istanbul and Antalya utilise next-generation genetic sequencing to identify tumour markers. This allows specialists to prescribe specific drugs like Keytruda. Patients avoid the long waiting lists often found in Australia.
Bookimed Expert Insight: The true advantage in Turkey lies in multidisciplinary tumour boards. Centres like Memorial Göztepe coordinate specialists across genetics, radiology, and oncology to review complex cases. This collaborative approach ensures targeted drugs are integrated perfectly with other treatments. It can potentially improve patient outcomes in stage 4 cases.
Patient Consensus: Patients value combining specialist second opinions with affordable diagnostic imaging. This includes tests like PET-CT scans. The seamless coordination between doctors and international patient teams in Turkey provides immense relief. This helps during stressful treatment periods.
Turkish oncology centres provide remote second opinions and preliminary treatment plans before patients leave Australia. Accredited hospitals like Anadolu Medical Center and Memorial Health Group use multidisciplinary tumour boards. These boards review pathology and genetic markers. This process confirms drug suitability and provides cost estimates before travel.
Bookimed Expert Insight: Anadolu Medical Center is affiliated with Johns Hopkins Medicine. This means their second opinions often follow the same strict oncology protocols used in the United States. This provides a high-level clinical benchmark for Australians comparing international options against local Medicare-funded treatments.
Patient Consensus: Patients find that remote reviews in Turkey often lead to more conservative, targeted approaches. These prioritise monitoring over immediate surgery. Getting a written plan first provides essential clarity on drug markers and schedules before booking flights.
Turkish hospitals provide comprehensive logistics and medical coordination for international patients receiving targeted therapy. Most JCI-accredited facilities, including Anadolu Medical Center and Hisar Hospital Intercontinental, operate dedicated international departments. These centres handle everything from second opinions to VIP airport transfers and multi-cycle treatment scheduling.
Bookimed Expert Insight: Anadolu Medical Center stands out for Australian patients due to its formal affiliation with Johns Hopkins Hospital. This partnership means targeted therapy protocols meet strict US clinical standards. Their international department acts as a single point of contact, managing complex drug supply chains often required for precision oncology.
Patient Consensus: Coordination teams help with pre-arrival paperwork and guide patients between hospital departments to reduce waiting times in Turkey. Patients appreciate the compassionate, 24/7 support provided during their diagnosis and treatment journey.